Abstract
Although oesophageal candidiasis is usually a superficial mucosal infection, necrotising Candida oesophagitis has been reported to cause oesophageal perforation or lung abscess. We report the case of an elderly Japanese man presenting with painless dysphagia after thoracic radiotherapy for oesophageal cancer. Non-contrast CT demonstrated segmental and oedematous thickening of the oesophageal wall. Endoscopy revealed white plaques on the oesophageal mucosa. The patient's oesophagitis responded to systemic antifungal therapy, and did not lead to oesophageal perforation. He died of recurrent oesophageal cancer several months later. The importance of severe radiation-induced oesophagitis without pain, our pathophysiological hypothesis on the local oedema caused by Candida infection and the usefulness of CT in evaluating abnormal thickening of the gastrointestinal tract are discussed separately in the article.
Background
Candida spp frequently colonise the upper aerodigestive tract and cause infection under several immunosuppressed conditions including diabetes mellitus1 and the post-radiotherapy state. Oropharyngeal candidiasis has been detected in 29% of patients undergoing head and neck radiotherapy,2 and oesophageal candidiasis was detected in 15% of patients undergoing thoracic radiotherapy.3
Oesophageal candidiasis is usually a superficial mucosal infection associated with white exudative plaques on the oesophageal mucosa.4 Although these plaques are sometimes visualised with oesophagitis caused by cytomegalovirus (CMV) or herpes simplex virus (HSV),5 empirical antifungal therapy is safe and cost-effective for oesophageal candidiasis.6
Necrotising Candida oesophagitis (NCE) is a life-threatening pathological condition. It is characterised by transmural inflammatory involvement extending to the oesophageal submucosa and muscle as well as mucosa, and leads to oesophageal perforation7 or lung abscess.8 Appropriate diagnostic techniques have not been well discussed in the literature.
Case presentation
A 78-year-old Japanese man was referred to our hospital for the treatment of oesophageal cancer. His medical history included diabetes mellitus, sepsis due to intramuscular abscess and cerebral infarction. He was diagnosed with clinical T3N1M0 stage IIIA middle thoracic oesophageal squamous cell carcinoma.
To conserve the antitumour effects of treatment9 without chemotherapy-induced neutropaenia, we scheduled two times per day hyperfractionated-involved field radiotherapy alone. The prescribed dose was 36 Gy/24 fractions at the isocentre from opposed anterior–posterior fields (figure 1), and 27 Gy/18 fractions from opposed oblique fields. Inspite of the patient's mild dysphagia, he was able to eat a regular diet throughout the 36-day treatment period.
Figure 1.

Anteroposterior portal X-ray image of the irradiation field.
Five weeks after the completion of radiotherapy, the patient visited our clinic and reported dysphagia, which had lasted for the prior 7 days. Pain on swallowing and fever were not present.
Investigations
Serum C reactive protein and β-d-glucan were negative. Non-contrast axial CT demonstrated symmetrical thickening of the upper and middle thoracic oesophagus (figure 2A, B). The attenuation of the thickened oesophageal wall was −2.7 HU (Hounsfield units) on average, which suggested submucosal oedema. Mediastinal fluid collection, pneumomediastinum and pleural effusion were absent.
Figure 2.

CT images before and after antifungal therapy. (A and B) Non-contrast axial CT showing oedematous thickening of the upper and middle thoracic oesophagus. (C and D) Contrast-enhanced CT at the same level on day 18 of fluconazole treatment. The thickness of the oesophageal wall decreased.
Two days after the CT scanning, an endoscopic examination revealed ill-defined oesophageal white plaques (figure 3A) and ulceration (figure 3B). A biopsy from the oedematous and fragile oesophageal wall, which was at high risk of perforation, was not performed.
Figure 3.

Endoscopic findings before antifungal therapy. (A) Ill-defined white plaques on the oesophageal mucosa. (B) Ulceration.
Differential diagnosis
White plaques on the oesophageal mucosa are observed in oesophagitis caused by Candida spp, CMV or HSV.
The patient's history of sepsis and inflammation extending into the oesophageal submucosa made NCE the most likely diagnosis. Absence of pain when swallowing was associated with diabetic neuropathy.
Treatment
On the day of the endoscopy, fluconazole was intravenously administered at a dose of 400 mg, then reduced to 300 mg daily from day 2 on. The dysphagia responded to antifungal therapy and the patient was again able to eat a semisolid diet. Fluconazole was reduced to 100 mg orally on day 7, and the dysphagia returned. Intravenous fluconazole was resumed at a dose of 400 mg on day 9. The patient's symptoms once again resolved, and oral itraconazole (200 mg) was started on day 17. Contrast-enhanced axial CT on day 18 showed a decrease in the oesophageal wall thickness (figure 2C, D). The total antifungal treatment period was 39 days.
Outcome and follow-up
The patient's dysphagia had not returned until the oesophageal cancer recurred at the primary tumour and upper mediastinal node outside the irradiation field 9 months after the beginning of radiotherapy. The patient died 20 days after the recurrence.
Discussion
We searched for case reports relevant to NCE in PubMed and found three articles.7 8 10 We also included another report regarding the case of oesophageal perforation due to angioinvasive Candida glabrata oesophagitis.11 Cases of concomitant bacterial infection were excluded. These cases are summarised in table 1.
Table 1.
Cases of necrotising Candida oesophagitis
| Age (years) | Sex | History | Extent of inflammation | Mortality | Reference number |
|---|---|---|---|---|---|
| 27 | M | Autism, renal failure | Pleura | Alive | 7 |
| 10 | M | Cardiac anomaly, Down syndrome, leukaemia | Pleura | Alive | 7 |
| 34 | F | Diabetic nephropathy | Lungs | Dead | 8 |
| 62 | M | Lymphoma | Oesophagus | Dead | 10 |
| 40 | F | Leukaemia | Pleura | Alive | 11 |
| 78 | M | Cerebral infarction, diabetes, oesophageal cancer, sepsis | Oesophagus | Died of cancer | Present case |
F, female; M, male.
The lessons learned from this case are summarised as follows: first, the pain related to oesophagitis is not always the initial presentation. Second, Candida infection causes oedematous thickening of the oesophageal wall. Finally, CT can clearly demonstrate abnormal thickening of the oesophageal wall.
Severe radiation-induced oesophagitis without pain is a major problem, because the destruction of the mural structure progresses without clinical attention. The discordance between symptoms related to oesophagitis and the gross mucosal appearance is reported in patients undergoing thoracic radiotherapy. In 7 of 82 patients, radiation-induced oesophagitis with a thickly coated ulcer or haemorrhage with or without stricture was endoscopically confirmed despite the patient's low symptom score on the radiation therapy oncology group acute radiation morbidity criteria.3
Candida infection causes local oedema of the oesophageal wall, and this seems to reflect the ability of Candida cells to adhere to blood vessels. An experimental rat model revealed that the degree of footpad skin oedema paralleled the number of Candida cells in the local lesion.12 A case of oesophageal perforation with angioinvasive Candida glabrata oesophagitis was reported; microscopically, fungal pseudohyphae were observed in the walls and lumina of blood vessels in the resected necrotic oesophagus.11 Candida albicans is known to interact with the vascular endothelium and various component proteins of the extracellular matrix.13
We hypothesise that injured or irradiated mucosa is prone to Candida infection, and that fungi affect the subepithelial venous plexus to cause a local circulatory disturbance and submucosal oedema.
CT is an excellent tool for detecting abnormal wall thickening of the gastrointestinal tract. Stratified, symmetrical and segmental thickening of the bowel wall is often associated with infectious enteritis, intestinal ischaemia or inflammatory bowel disease.14 This knowledge is applicable to non-neoplastic and oedematous thickening of the oesophageal wall.
Acute mucosal toxicities during head and neck irradiation are often associated with Candida infection, and prophylactic use of fluconazole during radiotherapy is reported to prevent severe oral mucositis and treatment interruption.15 Whether antifungal prophylaxis can prevent severe radiation-induced oesophagitis or oesophageal perforation should be determined in a randomised controlled trial.
Learning points.
Progressive dysphagia in immunocompromised patients arouses suspicion of necrotising Candida oesophagitis.
Pain is not always the initial presentation of oesophagitis.
Candida infection causes oedematous thickening of the oesophageal wall.
CT can clearly demonstrate abnormal thickening of the oesophageal wall.
Acknowledgments
The authors would like to thank Dr Aoyama for his valuable assistance.
Footnotes
Competing interests: None declared.
Patient consent: Obtained.
Provenance and peer review: Not commissioned; externally peer reviewed.
References
- 1.Dorocka-Bobkowska B, Budtz-Jörgensen E, Włoch S. Non-insulin-dependent diabetes mellitus as a risk factor for denture stomatitis. J Oral Pathol Med 1996;25:411–15. 10.1111/j.1600-0714.1996.tb00288.x [DOI] [PubMed] [Google Scholar]
- 2.Dahiya MC, Redding SW, Dahiya RS et al. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2003;57:79–83. 10.1016/S0360-3016(03)00415-2 [DOI] [PubMed] [Google Scholar]
- 3.Hirota S, Tsujino K, Hishikawa Y et al. Endoscopic findings of radiation esophagitis in concurrent chemoradiotherapy for intrathoracic malignancies. Radiother Oncol 2001;58:273–8. 10.1016/S0167-8140(00)00274-7 [DOI] [PubMed] [Google Scholar]
- 4.Wilcox CM, Schwartz DA. Endoscopic-pathologic correlates of Candida esophagitis in acquired immunodeficiency syndrome. Dig Dis Sci 1996;41:1337–45. 10.1007/BF02088557 [DOI] [PubMed] [Google Scholar]
- 5.Graman PS. Esophagitis. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases: 2-volume set. 8th edn Saunders, 2014:1248–52. [Google Scholar]
- 6.Wilcox CM, Alexander LN, Clark WS et al. Fluconazole compared with endoscopy for human immunodeficiency virus-infected patients with esophageal symptoms. Gastroenterology 1996;110:1803–9. 10.1053/gast.1996.v110.pm8964406 [DOI] [PubMed] [Google Scholar]
- 7.Gaissert HA, Breuer CK, Weissburg A et al. Surgical management of necrotizing Candida esophagitis. Ann Thorac Surg 1999;67:231–3. 10.1016/S0003-4975(98)01144-8 [DOI] [PubMed] [Google Scholar]
- 8.Jones JM, Glass NR, Belzer FO. Fatal Candida esophagitis in two diabetics after renal transplantation. Arch Surg 1982;117:499–501. 10.1001/archsurg.1982.01380280079016 [DOI] [PubMed] [Google Scholar]
- 9.Baumann M, Grégoire V. Modified fractionation. In: Joiner MC, van der Kogel A, eds. Basic clinical radiobiology. 4th edn CRC Press, 2009:135–48. [Google Scholar]
- 10.Jones JM. Necrotizing Candida esophagitis. Failure of symptoms and roentgenographic findings to reflect severity. JAMA 1980;244:2190–1. 10.1001/jama.1980.03310190042020 [DOI] [PubMed] [Google Scholar]
- 11.Tran HA, Vincent JM, Slavin MA et al. Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation. Clin Microbiol Infect 2003;9:1215–18. 10.1111/j.1469-0691.2003.00762.x [DOI] [PubMed] [Google Scholar]
- 12.Miller TE, Findon G. Experimental candidosis: paw oedema in the analysis of a local infection. J Med Microbiol 1985;20:283–90. 10.1099/00222615-20-3-283 [DOI] [PubMed] [Google Scholar]
- 13.Klotz SA. Fungal adherence to the vascular compartment: a critical step in the pathogenesis of disseminated candidiasis. Clin Infect Dis 1992;14:340–7. 10.1093/clinids/14.1.340 [DOI] [PubMed] [Google Scholar]
- 14.Macari M, Balthazar EJ. CT of bowel wall thickening: significance and pitfalls of interpretation. AJR Am J Roentgenol 2001;176:1105–16. 10.2214/ajr.176.5.1761105 [DOI] [PubMed] [Google Scholar]
- 15.Nicolatou-Galitis O, Velegraki A, Sotiropoulou-Lontou A et al. Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy. Support Care Cancer 2006;14:44–51. 10.1007/s00520-005-0835-2 [DOI] [PubMed] [Google Scholar]
